Skip to main content

SURMOUNT-4

Meaning

SURMOUNT-4 refers to a specific, Phase 3 clinical trial within a structured series of studies investigating the long-term efficacy and safety of the drug tirzepatide for chronic weight management. This particular trial was uniquely designed to assess a period of intensive weight loss followed by a randomized, controlled period of weight maintenance. The study’s design was crucial for understanding the sustained impact of the drug on preventing weight regain, a significant and persistent clinical challenge in obesity treatment.